血糖モニタリングシステム市場レポート：動向、予測、競合分析 (2031年まで)

世界の血糖モニタリングシステム市場の将来は、指先市場と代替部位市場に機会があり、有望視されています。世界の血糖モニタリングシステム市場は、2025年から2031年までのCAGRが7.5%で、2031年までに推定371億米ドルに達すると予想されます。この市場の主な促進要因は、糖尿病有病率の増加、高齢化による糖尿病感受性の増加、新製品リリースや糖尿病予防に対する意識の高まりです。

• Lucintel社によると、患者治療環境別では、糖尿病患者の増加やグルコース値の定期的なモニタリングに対する意識の高まりから、在宅医療が予測期間中最大のセグメントであり続けると予測しています。
• 検査部位カテゴリーでは、高精度と高信頼性により、指先検査が最大セグメントであり続けると思われます。
• 地域別では、北米が肥満率の上昇、高額医療、新製品導入、技術向上により、予測期間中も最大地域であり続けると思われます。

血糖モニタリングシステム市場の戦略的成長機会

戦略的観点からは、血糖モニタリングシステム市場は主要なアプリケーションの中で数多くの成長見込みがあります。概要は以下の通りです：

• 糖尿病の管理：糖尿病の管理：糖尿病管理のための高度なグルコースモニタリングシステムの採用は、成長機会を提示します。これらのシステムは、糖尿病をよりよく管理・治療するためのリアルタイムデータと洞察を提供します。
• 遠隔医療との統合：血糖モニタリングシステムを遠隔医療プラットフォームと統合することで、成長の展望も開けます。これにより、遠隔モニタリングとコンサルテーションが可能になり、ケアの質と患者管理が向上します。
• 手頃な価格でのモニタリングソリューションの提供：低所得者や発展途上地域向けに手頃な価格のグルコースモニタリング機器を開発することは、大きな成長機会となります。これらのソリューションは、糖尿病管理ツールへのアクセスを拡大し、世界の健康アウトカムを改善します。
• ウェアラブル技術：グルコースモニタリングシステムをウェアラブル技術と統合することで、成長の可能性が広がります。ウェアラブル端末は、他の健康指標とともに持続的なグルコースモニタリングをサポートし、包括的な健康管理を促進します。
• 個別化医療：個別化医療をサポートするグルコースモニタリングデータには成長機会があります。個々のグルコースパターンと反応に合わせて糖尿病管理を調整することで、治療効果と患者の転帰が向上します。

こうした新たな機会が市場の成長と開拓を促進し、血糖モニタリングシステムの有効性と普及率を向上させています。

血糖モニタリングシステム市場促進要因・課題

血糖モニタリングシステム市場は、様々な技術的、経済的、規制的要因に影響される成長の可能性を示す成長市場です。ここでは、主要な促進要因と課題について紹介します：

血糖モニタリングシステム市場を牽引する要因は以下の通り：

• 技術進歩：CGMと非侵襲的なグルコースモニタリング技術の改善と革新は、ユーザーのための精度と利便性を向上させます。これが市場成長の促進要因となっています。
• 糖尿病有病率の増加：世界の有病率の上昇は、効果的なグルコースモニタリングソリューションに対する需要の伸びを促進し、市場の拡大をさらに後押しします。
• デジタルヘルスへの統合：グルコースモニタのデジタルヘルスプラットフォームへの統合が進み、データ管理と患者エンゲージメントが強化され、市場の成長を支えています。
• 個別化の重視：個別化医療と個別化治療計画の進展が、高度なグルコースモニタリングシステムに対するニーズを促進しています。
• 手頃な価格のソリューション：費用対効果の高いグルコースモニタリングデバイスの開発は、市場へのアクセスを拡大し、十分なサービスを受けていない地域での成長を促進しています。

血糖モニタリングシステム市場における課題は以下の通りです：

• 高コスト：高度な血糖モニタリングシステムは高価であり、特に低所得地域や保険未加入者層での導入が少ないです。
• 規制上のハードル：新技術の承認取得は複雑で時間がかかるため、製品の発売や市場参入が遅れる可能性があります。

これらの市場促進要因・課題は、今後も血糖モニタリングシステム市場に影響を与え、その成長軌道と利害関係者の戦略的意思決定を形成していくでしょう。

目次

第1章 エグゼクティブサマリー

第2章 世界の血糖モニタリングシステム市場：市場力学

• イントロダクション、背景、分類
• サプライチェーン
• 業界の促進要因と課題

第3章 市場動向と予測分析 (2019年～2031年)

• マクロ経済動向 (2019～2024年) と予測 (2025～2031年)
• 世界の血糖モニタリングシステム市場の動向 (2019～2024年) と予測 (2025～2031年)
• 世界の血糖モニタリングシステム市場：検査部位別
  • 指先
  • 代替部位
• 世界の血糖モニタリングシステム市場：製品別
  • 自己モニタリング
  • 持続血糖測定装置
• 世界の血糖モニタリングシステム市場：患者治療環境別
  • 病院
  • 在宅医療
• 世界の血糖モニタリングシステム市場：用途別
  • 1型糖尿病
  • 2型糖尿病
  • 妊娠糖尿病
  • その他

第4章 地域別の市場動向と予測分析 (2019年～2031年)

• 世界の血糖モニタリングシステム市場：地域別
• 北米の血糖モニタリングシステム市場
• 欧州の血糖モニタリングシステム市場
• アジア太平洋の血糖モニタリングシステム市場
• その他地域の血糖モニタリングシステム市場

第5章 競合分析

• 製品ポートフォリオ分析
• 運用統合
• ポーターのファイブフォース分析

第6章 成長機会と戦略分析

• 成長機会分析
  • 世界の血糖モニタリングシステム市場の成長機会：検査部位別
  • 世界の血糖モニタリングシステム市場の成長機会：製品別
  • 世界の血糖モニタリングシステム市場の成長機会：患者治療環境別
  • 世界の血糖モニタリングシステム市場の成長機会：用途別
  • 世界の血糖モニタリングシステム市場の成長機会：地域別
• 世界の血糖モニタリングシステム市場の新たな動向
• 戦略的分析
  • 新製品の開発
  • 世界の血糖モニタリングシステム市場の生産能力拡大
  • 世界の血糖モニタリングシステム市場における企業合併・買収 (M&A)、合弁事業
  • 認証とライセンシング

第7章 主要企業のプロファイル

• Thermos Fisher Scientific
• Promega
• Agilent Technologies
• Bio-Rad Laboratories
• QIAGEN
• Merck
• B.D.
• Sanofi
• Ascensia Diabetes Care Holdings
• Abbott

The future of the global blood glucose monitoring system market looks promising with opportunities in the fingertip and alternate site markets. The global blood glucose monitoring system market is expected to reach an estimated $37.1 billion by 2031 with a CAGR of 7.5% from 2025 to 2031. The major drivers for this market are the growing prevalence of diabetes, the aging population's increased susceptibility to the disease, as well as, raising awareness of new product releases and diabetes prevention.

• Lucintel forecasts that, within the patient care setting category, homecare will remain the largest segment over the forecast period due to the rising number of diabetic patients and increasing awareness about regular monitoring of glucose levels.
• Within the testing site category, fingertip testing will remain the largest segment due to high accuracy and high reliability.
• In terms of regions, North America will remain the largest region over the forecast period due to rising rates of obesity, expensive medical care, new product introductions, and technology improvements in the region.

Gain valuable insights for your business decisions with our comprehensive 150+ page report.

Emerging Trends in the Blood Glucose Monitoring System Market

The blood glucose monitoring system market has created current trends that are shaping its future. Here's an overview:

• Continuous Glucose Monitoring: Currently, continuous glucose monitoring (CGM) systems are gaining more demand because they offer real-time glucose information and trends. These systems improve diabetes management by continuously presenting glucose levels, thereby reducing the need for multiple fingerstick tests.
• Integration with Digital Health Platforms: There is an increasing trend of integrating glucose monitoring systems into digital health platforms and apps for better management, analysis, and communication between patients and healthcare professionals.
• Non-Invasive Technologies: There is significant interest in the development of non-invasive glucose monitoring technologies. These technologies aim to provide accurate glucose measurements without requiring blood samples, making it easier and more comfortable for users.
• Smartphone Connectivity: Monitors with smartphone connectivity are gaining momentum. These devices allow users to access their glucose levels and manage their data through various mobile applications, facilitating easy access and usability.
• Affordability: The market is moving towards finding more affordable solutions for monitoring blood glucose. Lower-priced devices are making diabetes management more accessible in poorer and underdeveloped regions worldwide.

These trends act as catalysts for innovation, extending the use of blood glucose monitoring systems and enhancing their role in diabetes management and patient care.

Recent Developments in the Blood Glucose Monitoring System Market

There have been several key developments in the blood glucose monitoring system market. An overview follows:

• Improving CGM: Continuous glucose monitoring systems now boast better accuracy and extended wear times, providing more detailed glucose data and better support for diabetes management.
• Non-Invasive Monitoring: Non-invasive glucose monitoring technology is under development, with new devices emerging that reduce the pain and discomfort associated with traditional blood glucose testing.
• Integration of Glucose Monitors with Mobile Health: Recent innovations include integrating glucose monitors with mobile health apps and platforms. These integrations enhance data tracking and improve interaction between patients and healthcare providers.
• Cost-Effective Solutions: Novel blood glucose meters are being introduced with a focus on cost-effectiveness. These provide essential features at lower prices, increasing access among larger populations.
• Improved Accuracy and Precision: Advances in sensor technology are enabling the development of more accurate and precise blood glucose monitoring systems, thereby increasing the reliability of glucose measurements and improving diabetes management.

These developments enhance the functionality of blood glucose monitoring systems by improving accuracy, access, and user convenience in diabetes management.

Strategic Growth Opportunities for Blood Glucose Monitoring System Market

From a strategic perspective, the blood glucose monitoring system market has numerous growth prospects within key applications. A brief overview follows:

• Management of Diabetes: The adoption of advanced glucose monitoring systems for diabetes management presents a growing opportunity. These systems provide real-time data and insights to better control and treat diabetes.
• Integration with Telehealth: Integrating blood glucose monitoring systems with telehealth platforms also opens up growth prospects. This enables remote monitoring and consultations, improving the quality of care and patient management.
• Offering Monitoring Solutions at Affordable Prices: Developing affordable glucose monitoring devices for low-income and developing regions represents a significant growth opportunity. These solutions will broaden access to diabetes management tools and improve global health outcomes.
• Wearable Technology: Integrating glucose monitoring systems with wearable technology opens potential avenues for growth. Wearable devices support continuous glucose monitoring along with other health metrics, facilitating comprehensive health management.
• Personalized Medicine: There are growth opportunities in glucose monitoring data that support personalized medicine. Tailoring diabetes management to individual glucose patterns and responses enhances treatment effectiveness and patient outcomes.

These emerging opportunities are fostering market growth and development, and improving the efficacy and reach of blood glucose monitoring systems.

Blood Glucose Monitoring System Market Driver and Challenges

The blood glucose monitoring system market is a growth market exhibiting possibilities for growth that are influenced by various technological, economic, and regulatory factors. A glance at the key drivers and challenges has been presented here:

The factors responsible for driving the blood glucose monitoring system market include:

• Technological Advances: Improvement and innovation in monitoring technologies of glucose, both CGM and non-obtrusive, better the accuracy and convenience for the user. This acts as a driver to market growth.
• Growing Diabetes Prevalence: The rise in global prevalence propels the growth in demand for effective glucose monitoring solutions, further supporting the market's expansion.
• Integration into Digital Health: Glucose monitors are increasingly being integrated into digital health platforms, enhancing data management and patient engagement, hence assisting the market to grow.
• More Emphasis on Personalization: Advancing personalized medicine and personalized treatment plans is driving the need for advanced glucose monitoring systems.
• Affordable Solutions: The development of cost-effective glucose monitoring devices is expanding market access and driving growth in underserved regions.

Challenges in the blood glucose monitoring system market are:

• High Costs: Advanced glucose monitoring systems are expensive, and their adoption is particularly low in low-income regions and among non-insured populations.
• Regulatory Hurdles: Navigating regulatory approvals for new technologies can be complex and time-consuming, potentially delaying product launches and market entry.

These drivers and challenges will continue to influence the blood glucose monitoring system market and shape its growth trajectory and strategic decisions of the stakeholders.

List of Blood Glucose Monitoring System Companies

Companies in the market compete based on product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. Through these strategies, blood glucose monitoring system companies cater to increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the blood glucose monitoring system companies profiled in this report include-

• Thermos Fisher Scientific
• Promega
• Agilent Technologies
• Bio-Rad Laboratories
• QIAGEN
• Merck
• B.D.
• Sanofi
• Ascensia Diabetes Care Holdings
• Abbott

Blood Glucose Monitoring System by Segment

The study includes a forecast for the global blood glucose monitoring system market by testing site, product, patient care setting, application, and region.

Blood Glucose Monitoring System Market by Testing Site [Analysis by Value from 2019 to 2031]:

• Fingertip
• Alternate Site

Blood Glucose Monitoring System Market by Product [Analysis by Value from 2019 to 2031]:

• Self-Monitoring
• Continuous Glucose Monitoring Devices

Blood Glucose Monitoring System Market by Patient Care Setting [Analysis by Value from 2019 to 2031]:

• Hospital
• Homecare

Blood Glucose Monitoring System Market by Application [Analysis by Value from 2019 to 2031]:

• Type 1
• Type 2
• Gestational Diabetes
• Others

Blood Glucose Monitoring System Market by Region [Analysis by Value from 2019 to 2031]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

Country Wise Outlook for the Blood Glucose Monitoring System Market

Blood glucose monitoring systems represent one of the fastest-growing markets, replacing conventional products with technologically advanced ones and increasing demand for diabetes management. Here is an overview of recent trends in major countries:

• United States: The introduction of real-time continuous glucose monitoring systems that deliver real-time glucose readings marks a significant development in the U.S. market. Integration with smartphones and wearables is continuously modernizing user convenience for easier data access.
• China: China remains a high-growth market due to the rising penetration of low-cost blood glucose meters and CGMs, driven by greater disease awareness and healthcare reforms. Innovations in lower-cost monitoring solutions are making diabetes management more accessible to a broader population.
• Germany: Germany is progressing in developing non-invasive glucose monitoring technology and improving the accuracy of glucose testing. Ongoing research aims to increase the reliability of these systems and integrate them into digital health platforms for more effective diabetes management.
• India: The market is expected to grow due to the introduction of more affordable blood glucose monitoring devices and increased access to continuous glucose monitoring. This will improve accessibility to diabetes management tools in both urban and rural settings.
• Japan: Japan is at the forefront of integrating other health monitoring technologies into advanced glucose monitoring systems. Its focus is on developing systems capable of providing comprehensive health data, including glucose levels, for personalized treatment plans.

Features of the Global Blood Glucose Monitoring System Market

Market Size Estimates: Blood glucose monitoring system market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2019 to 2024) and forecast (2025 to 2031) by various segments and regions.

Segmentation Analysis: Blood glucose monitoring system market size by various segments, such as by testing site, product, patient care setting, application, and region in terms of value ($B).

Regional Analysis: Blood glucose monitoring system market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different testing sites, products, patient care settings, applications, and regions for the blood glucose monitoring system market.

Strategic Analysis: This includes M&A, new product development, and the competitive landscape of the blood glucose monitoring system market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

If you are looking to expand your business in this market or adjacent markets, then contact us. We have done hundreds of strategic consulting projects in market entry, opportunity screening, due diligence, supply chain analysis, M&A, and more.

This report answers the following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the blood glucose monitoring system market by testing site (fingertip and alternate site), product (self-monitoring and continuous glucose monitoring devices), patient care setting (hospital and homecare), application (type 1, type 2, gestational diabetes, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Blood Glucose Monitoring System Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2019 to 2031

• 3.1. Macroeconomic Trends (2019-2024) and Forecast (2025-2031)
• 3.2. Global Blood Glucose Monitoring System Market Trends (2019-2024) and Forecast (2025-2031)
• 3.3: Global Blood Glucose Monitoring System Market by Testing Site
  • 3.3.1: Fingertip
  • 3.3.2: Alternate Site
• 3.4: Global Blood Glucose Monitoring System Market by Product
  • 3.4.1: Self-Monitoring
  • 3.4.2: Continuous Glucose Monitoring Devices
• 3.5: Global Blood Glucose Monitoring System Market by Patient Care Setting
  • 3.5.1: Hospital
  • 3.5.2: Homecare
• 3.6: Global Blood Glucose Monitoring System Market by Application
  • 3.6.1: Type 1
  • 3.6.2: Type 2
  • 3.6.3: Gestational Diabetes
  • 3.6.4: Others

4. Market Trends and Forecast Analysis by Region from 2019 to 2031

• 4.1: Global Blood Glucose Monitoring System Market by Region
• 4.2: North American Blood Glucose Monitoring System Market
  • 4.2.1: North American Market by Testing Site: Fingertip and Alternate Site
  • 4.2.2: North American Market by Patient Care Setting: Hospital and Homecare
• 4.3: European Blood Glucose Monitoring System Market
  • 4.3.1: European Market by Testing Site: Fingertip and Alternate Site
  • 4.3.2: European Market by Patient Care Setting: Hospital and Homecare
• 4.4: APAC Blood Glucose Monitoring System Market
  • 4.4.1: APAC Market by Testing Site: Fingertip and Alternate Site
  • 4.4.2: APAC Market by Patient Care Setting: Hospital and Homecare
• 4.5: ROW Blood Glucose Monitoring System Market
  • 4.5.1: ROW Market by Testing Site: Fingertip and Alternate Site
  • 4.5.2: ROW Market by Patient Care Setting: Hospital and Homecare

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Blood Glucose Monitoring System Market by Testing Site
  • 6.1.2: Growth Opportunities for the Global Blood Glucose Monitoring System Market by Product
  • 6.1.3: Growth Opportunities for the Global Blood Glucose Monitoring System Market by Patient Care Setting
  • 6.1.4: Growth Opportunities for the Global Blood Glucose Monitoring System Market by Application
  • 6.1.5: Growth Opportunities for the Global Blood Glucose Monitoring System Market by Region
• 6.2: Emerging Trends in the Global Blood Glucose Monitoring System Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Blood Glucose Monitoring System Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Blood Glucose Monitoring System Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: Thermos Fisher Scientific
• 7.2: Promega
• 7.3: Agilent Technologies
• 7.4: Bio-Rad Laboratories
• 7.5: QIAGEN
• 7.6: Merck
• 7.7: B.D.
• 7.8: Sanofi
• 7.9: Ascensia Diabetes Care Holdings
• 7.10: Abbott